ATE517105T1 - Neue imidazolon-derivate, wirkstoffpräparat daraus, pharmazeutische zusammensetzungen und ihre verwendung als hemmer von proteinkinasen, insbesondere cdc7 - Google Patents
Neue imidazolon-derivate, wirkstoffpräparat daraus, pharmazeutische zusammensetzungen und ihre verwendung als hemmer von proteinkinasen, insbesondere cdc7Info
- Publication number
- ATE517105T1 ATE517105T1 AT07858418T AT07858418T ATE517105T1 AT E517105 T1 ATE517105 T1 AT E517105T1 AT 07858418 T AT07858418 T AT 07858418T AT 07858418 T AT07858418 T AT 07858418T AT E517105 T1 ATE517105 T1 AT E517105T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- pharmaceutical compositions
- active ingredients
- protein kinases
- imidazolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0608924A FR2907120B1 (fr) | 2006-10-12 | 2006-10-12 | Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7 |
PCT/FR2007/001651 WO2008046982A2 (fr) | 2006-10-12 | 2007-10-10 | Nouveaux derives imidazolones, leur preparation a titre de medicaments, compositions pharmaceutiques, utilisation comme inhibiteurs de proteines kinases notamment cdc7 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE517105T1 true ATE517105T1 (de) | 2011-08-15 |
Family
ID=37964098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07858418T ATE517105T1 (de) | 2006-10-12 | 2007-10-10 | Neue imidazolon-derivate, wirkstoffpräparat daraus, pharmazeutische zusammensetzungen und ihre verwendung als hemmer von proteinkinasen, insbesondere cdc7 |
Country Status (29)
Country | Link |
---|---|
US (1) | US8314121B2 (de) |
EP (1) | EP2094699B1 (de) |
JP (1) | JP2010505922A (de) |
KR (1) | KR101552361B1 (de) |
CN (1) | CN101522678A (de) |
AR (1) | AR063249A1 (de) |
AT (1) | ATE517105T1 (de) |
AU (1) | AU2007311833B2 (de) |
BR (1) | BRPI0719790A2 (de) |
CA (1) | CA2660166C (de) |
CL (1) | CL2007002934A1 (de) |
CO (1) | CO6160310A2 (de) |
CY (1) | CY1112066T1 (de) |
DK (1) | DK2094699T3 (de) |
EA (1) | EA018496B1 (de) |
ES (1) | ES2370049T3 (de) |
FR (1) | FR2907120B1 (de) |
HR (1) | HRP20110759T1 (de) |
IL (1) | IL197452A (de) |
MA (1) | MA30877B1 (de) |
MX (1) | MX2009003283A (de) |
NO (1) | NO20091486L (de) |
PL (1) | PL2094699T3 (de) |
PT (1) | PT2094699E (de) |
RS (1) | RS51985B (de) |
SI (1) | SI2094699T1 (de) |
TW (1) | TW200821310A (de) |
UY (1) | UY30642A1 (de) |
WO (1) | WO2008046982A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010122979A1 (ja) | 2009-04-20 | 2010-10-28 | Sbiバイオテック株式会社 | チアゾリジノン誘導体 |
CN102471339A (zh) * | 2009-07-15 | 2012-05-23 | 雅培制药有限公司 | 激酶的吡咯并吡啶抑制剂 |
CN102762208A (zh) * | 2009-12-04 | 2012-10-31 | 赛林药物股份有限公司 | 作为ck2抑制剂的吡唑嘧啶和相关杂环 |
JP2013525354A (ja) * | 2010-04-19 | 2013-06-20 | アッヴィ・インコーポレイテッド | ピロロピリジン系キナーゼ阻害薬 |
DK2692728T3 (en) | 2011-03-31 | 2018-10-08 | Carna Biosciences Inc | UNKNOWN FURANONDERIVATE |
US9974795B2 (en) | 2014-01-31 | 2018-05-22 | Carna Biosciences, Inc. | Anticancer agent composition |
GB201807147D0 (en) | 2018-05-01 | 2018-06-13 | Oncologica Uk Ltd | Therapeutic combination |
US20230129364A1 (en) * | 2019-12-26 | 2023-04-27 | Yonsei University, University - Industry Foundation (UIF) | Pyrrolidine derivative, and pharmaceutical composition for preventing or treating beta-amyloid or tau protein-associated diseases containing same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6335342B1 (en) | 2000-06-19 | 2002-01-01 | Pharmacia & Upjohn S.P.A. | Azaindole derivatives, process for their preparation, and their use as antitumor agents |
EP2295433A3 (de) | 2003-03-06 | 2011-07-06 | Eisai R&D Management Co., Ltd. | JNK Inhibitoren |
EP1660475B1 (de) * | 2003-08-08 | 2008-05-28 | Pfizer Italia S.r.l. | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken |
KR20070002081A (ko) | 2004-04-02 | 2007-01-04 | 버텍스 파마슈티칼스 인코포레이티드 | Rock 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌 |
CA2582986A1 (en) * | 2004-10-14 | 2006-04-20 | Shaoqing Chen | Novel azaindole thiazolinones as anti-cancer agents |
US7371862B2 (en) * | 2005-11-11 | 2008-05-13 | Pfizer Italia S.R.L. | Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
-
2006
- 2006-10-12 FR FR0608924A patent/FR2907120B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-10 RS RS20110456A patent/RS51985B/en unknown
- 2007-10-10 CN CNA2007800378600A patent/CN101522678A/zh active Pending
- 2007-10-10 AT AT07858418T patent/ATE517105T1/de active
- 2007-10-10 EA EA200970364A patent/EA018496B1/ru not_active IP Right Cessation
- 2007-10-10 JP JP2009531874A patent/JP2010505922A/ja not_active Revoked
- 2007-10-10 PL PL07858418T patent/PL2094699T3/pl unknown
- 2007-10-10 ES ES07858418T patent/ES2370049T3/es active Active
- 2007-10-10 CA CA2660166A patent/CA2660166C/fr not_active Expired - Fee Related
- 2007-10-10 KR KR1020097007392A patent/KR101552361B1/ko not_active IP Right Cessation
- 2007-10-10 BR BRPI0719790-0A2A patent/BRPI0719790A2/pt not_active IP Right Cessation
- 2007-10-10 DK DK07858418.2T patent/DK2094699T3/da active
- 2007-10-10 AU AU2007311833A patent/AU2007311833B2/en not_active Ceased
- 2007-10-10 PT PT07858418T patent/PT2094699E/pt unknown
- 2007-10-10 SI SI200730750T patent/SI2094699T1/sl unknown
- 2007-10-10 EP EP07858418A patent/EP2094699B1/de active Active
- 2007-10-10 MX MX2009003283A patent/MX2009003283A/es active IP Right Grant
- 2007-10-10 WO PCT/FR2007/001651 patent/WO2008046982A2/fr active Application Filing
- 2007-10-11 AR ARP070104500A patent/AR063249A1/es unknown
- 2007-10-11 CL CL200702934A patent/CL2007002934A1/es unknown
- 2007-10-12 UY UY30642A patent/UY30642A1/es not_active Application Discontinuation
- 2007-10-12 TW TW096138357A patent/TW200821310A/zh unknown
-
2009
- 2009-03-05 IL IL197452A patent/IL197452A/en not_active IP Right Cessation
- 2009-03-31 US US12/415,391 patent/US8314121B2/en not_active Expired - Fee Related
- 2009-04-08 CO CO09036259A patent/CO6160310A2/es unknown
- 2009-04-16 NO NO20091486A patent/NO20091486L/no not_active Application Discontinuation
- 2009-05-08 MA MA31856A patent/MA30877B1/fr unknown
-
2011
- 2011-10-19 HR HR20110759T patent/HRP20110759T1/hr unknown
- 2011-10-20 CY CY20111100996T patent/CY1112066T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE517105T1 (de) | Neue imidazolon-derivate, wirkstoffpräparat daraus, pharmazeutische zusammensetzungen und ihre verwendung als hemmer von proteinkinasen, insbesondere cdc7 | |
DE602006019953D1 (de) | Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90 | |
ATE432925T1 (de) | Neue imidazolcarboxamid-derivate als fructose-1,6-bisphosphatase-hemmer und pharmazeutische zusammensetzungen damit | |
BRPI0515489A (pt) | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase | |
BRPI0515478A (pt) | derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase | |
ATE517621T1 (de) | Verwendung von ampk-aktivierenden imidazol- derivaten, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen | |
BRPI0515505A (pt) | derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
CY2015043I2 (el) | Ενωσεις και συνθεσεις ως αναστολεις των πρωτεϊνικων κινασων | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
UA99617C2 (ru) | Производные пирролконденсированного азотсодержащего гетероцикла, их получение и фармацевтическое применение | |
ATE538125T1 (de) | Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren | |
BRPI0508263B8 (pt) | derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina | |
EP2476679A3 (de) | Substituierte Triazole als AXL-Hemmer | |
EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
ATE492545T1 (de) | Verbindungen und zusammensetzungen als proteinkinase-hemmer | |
DE602005026395D1 (de) | Neue zyklische harnstoffderivate, deren herstellung und pharmazeutische verwendung damit als kinase-inhibitoren | |
CR10755A (es) | Compounds and compositions as protein kinase inhibitors | |
ATE377597T1 (de) | Anilinochinazoline als protein-tyrosin- kinasehemmer | |
BRPI0515500A (pt) | derivados piridazina para inibição de estearoil-coa-desaturase | |
BRPI0617162A2 (pt) | Compostos inibidores de fosfatidilinositol 3-quinase, composições farmacêuticas que os contem e métodos de uso dos mesmos | |
BRPI0512938A (pt) | derivados da quinazolinediona como inibidores parp | |
CL2011000230A1 (es) | Anticuerpo monoclonal humano aislado que se une al inhibidor de la via del factor tisular (tfpi); composicion farmaceutica que lo comprende; uso para tratar deficiencias adquiridas o geneticas de la coagulacion, o para acortar el tiempo de sangrado. | |
BRPI0920261A2 (pt) | Composto, composição farmacêutica, uso do composto, e, método para inibir ou modular atividade de proteína quinase em uma amostra biológica | |
CL2007003635A1 (es) | Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2094699 Country of ref document: EP |